throbber

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`MYLAN INSTITUTIONAL LLC,
`Petitioner,
`
`v.
`
`NOVO NORDISK A/S,
`Patent Owner.
`______________
`
`Case IPR2020-00324
`Patent 8,114,833
`______________
`
`
`PATENT OWNER’S NOTICE OF SUPPLEMENTAL EVIDENCE IN
`RESPONSE TO PETITIONER’S OBJECTIONS TO EXHIBITS
`
`
`
`
`

`

`
`
`IPR2020-00324
`Patent 8,114,833
`Patent Owner Novo Nordisk A/S (“Novo Nordisk”) submits this Notice of
`
`
`
`Supplemental Evidence in Response to Petitioner Mylan Institutional LLC’s
`
`(“Mylan”) Objections to Patent Owner’s Evidence dated September 25, 2020. In
`
`response to Mylan’s objections, Novo Nordisk serves herewith supplemental
`
`evidence, identified as Exhibits 2083, 2084, 2085, 2086, 2087, 2088, 2089, 2090,
`
`2091, 2092, 2093, and 2094 pursuant to 37 C.F.R. § 42.64(b)(2). Novo Nordisk
`
`further serves herewith its Amended List of Exhibits pursuant to 37 C.F.R. §
`
`42.63(e), identifying its supplemental evidence.
`
`Mylan objected to Exhibit Nos. 2051, 2052, 2053, 2055, 2057, 2058, 2059,
`
`2060, 2062, 2063, 2065, and 2069 (collectively, the “Translated Exhibits”) under 37
`
`C.F.R. § 42.63(b) as “failing to file an affidavit.” The only context for its objection
`
`that Mylan provided was: “the translation filed with the underlying document is not
`
`filed with an affidavit in accordance with 37 C.F.R. § 42.63(b).” Paper 23 at 11.
`
`37 C.F.R. 42.63(b) states: “When a party relies on a document or is required
`
`to produce a document in a language other than English, a translation of the
`
`document into English and an affidavit attesting to the accuracy of the translation
`
`must be filed with the document.”
`
`The Translated Exhibits did include affidavits attesting to the accuracy of the
`
`translation, along with the original Danish language document and certified English
`
`translation thereof. Mylan has not explained its position as to why the original
`
`
`
`1
`
`

`

`IPR2020-00324
`Patent 8,114,833
`affidavits were allegedly not in accordance with 37 C.F.R. § 42.63(b). Mylan’s
`
`
`
`objection therefore does not “identify the grounds for the objection with sufficient
`
`particularity to allow correction in the form of supplemental evidence,” as is required
`
`under 37 C.F.R. § 42.64(b)(1).
`
`Nevertheless, in an effort to resolve Mylan’s objections under 37 C.F.R. §
`
`42.63(b)(1), Novo Nordisk serves herewith as supplemental evidence a copy of each
`
`Translated Exhibit, which includes a supplemental affidavit. Inclusion of the
`
`supplemental affidavit with each Translated Exhibit should resolve Mylan’s
`
`objections under 37 C.F.R. § 42.63(b)(1), despite Mylan’s failure to clearly articulate
`
`the grounds for its objections.
`
`Novo Nordisk reserves all rights to respond to any further explanations Mylan
`
`may be allowed to provide regarding its evidentiary objections. Novo Nordisk’s
`
`service of supplemental evidence is timely under 37 C.F.R. § 42.64(b)(2) because it
`
`is served within 10 business days of the service of Mylan’s objections.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`-2-
`
`

`

`
`Dated: October 9, 2020
`
`
`
`
`
`
`
`
`
`
`
`IPR2020-00324
`Patent 8,114,833
`
`Respectfully submitted,
`
`/s/ Jeffrey J. Oelke (Electronically signed)
`Jeffrey J. Oelke, Reg. No. 37,409
`Lead Counsel
`
`Ryan P. Johnson
`Laura T. Moran
`Back-Up Counsel
`
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, NY 10010
`(212) 430-2600
`joelke@fenwick.com
`ryan.johnson@fenwick.com
`laura.moran@fenwick.com
`
`Counsel for Patent Owner Novo Nordisk A/S
`
`
`
`-3-
`
`

`

`
`
`CERTIFICATE OF SERVICE
`
`IPR2020-00324
`Patent 8,114,833
`
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on October 9, 2020, the
`
`foregoing document is being served by filing this document through the Patent Trial and
`
`Appeal Board End to End System, as well as by delivering a copy via electronic mail
`
`upon the following counsel of record for the Petitioner:
`
`Brandon M. White (Reg. No. 52,354)
`Perkins Coie LLP
`700 Thirteenth Street, N.W., Suite 600
`Washington, D.C. 20005
`Telephone: (202) 654-6206
`BMWhite@perkinscoie.com
`White-ptab@perkinscoie.com
`
`Lara Dueppen (Reg. No. 65,002)
`Perkins Coie LLP
`1888 Century Park East
`Suite 1700
`Los Angeles, CA 90067
`Telephone: (310) 788-3349
`LDueppen@perkinscoie.com
`Dueppen-ptab@perkinscoie.com
`Liraglutide@perkinscoie.com
`
`
`
`
`
`
`Respectfully submitted,
`
`/s/ Jeffrey J. Oelke (Electronically signed)
`Jeffrey J. Oelke, Reg. No. 37,409
`Lead Counsel
`
`-4-
`
`
`
`
`
`
`
`
`
`Date: October 9, 2020
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket